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Abstract
Introduction: Peritoneal mesothelioma is a rare tumor with diagnostic and therapeutic problems.
The peritoneum is the second most common site for development of mesothelioma, which in 30–
45% of cases is associated with a synchronous pleural mesothelioma. Clinical symptoms and findings
may be confusing and diagnosis can be easily overlooked especially in cases where there is no
previous asbestos exposure.
Case presentation: We report a case of malignant peritoneal mesothelioma in a 75-year-old
woman who presented with ascites which, in the absence of inhalational exposure to asbestos,
caused diagnostic confusion, and evaded radiological detection.
Conclusion: We concluded from this case that Peritoneal Mesothelioma although rare but should
be considered among the differential diagnosis of Ascites.
Introduction
Malignant mesothelioma of the peritoneum is rare but
rapidly fatal malignancy. The median survival rang from 5
to 12 months, mainly because of lack of effective treat-
ment. The incidence is approximately one per 1,000,000;
approximately one fifth to one third of all mesotheliomas
are peritoneal. Half of reported cases have a history of
asbestos exposure. The diagnosis of peritoneal mesotheli-
oma is often delayed, in part because of the usually long
latent period (peaking at 40–45 years from the time of ini-
tial exposure to asbestos) and because the common pre-
senting symptoms of weight loss, usually with a full
abdomen, malaise, and abdominal discomfort, are mild
and nonspecific. Because of its unusual nature, the disease
has not been clearly defined in terms of its natural history,
diagnosis, or management. Treatment options with intra-
venous chemotherapy are far from satisfactory. However,
because malignant peritoneal mesothelioma usually
remains confined to the peritoneal cavity for most of its
natural history, regional chemotherapy is an attractive
option.
Case presentation
A 75-year-old woman was admitted with a five-week his-
tory of progressive dyspnoea, ascites, leg edema and leth-
argy. She had a previous history of pulmonary
tuberculosis 50 years earlier and hypertension which was
well controlled with atenolol. She had never smoked and
had no known previous exposure to asbestos. She had a
family history of lung and large bowel cancer but no his-
tory of mesothelioma.
Published: 25 April 2008
Journal of Medical Case Reports 2008, 2:121 doi:10.1186/1752-1947-2-121
Received: 19 July 2007
Accepted: 25 April 2008
This article is available from: http://www.jmedicalcasereports.com/content/2/1/121
© 2008 Ahmed et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Medical Case Reports 2008, 2:121 http://www.jmedicalcasereports.com/content/2/1/121
Page 2 of 4
(page number not for citation purposes)
Clinical examination revealed bilateral pedal pitting
edema but no signs of chronic liver disease. She had mod-
erate ascites but normal cardiovascular and respiratory
system examinations. Blood investigations including full
blood count (FBC), urea and electrolytes, liver function
tests (LFTs), inflammatory markers, hepatitis, viral and
autoimmune screens were all normal. Initial ultrasound
scan and computed tomography (CT) scan of the abdo-
men and pelvis were unable to demonstrate any signifi-
cant abdominal pathology other than ascites. A diagnostic
ascitic tap yielded transudate with a serum ascites-albu-
min gradient (SA-AG) of 32. Ascitic fluid culture and cul-
ture for acid-fast bacilli (AFB) were also negative. The
ascites recurred despite multiple drainages. She had a
repeat CT scan which showed extensive peritoneal nodu-
larity and omental cake along with massive ascites. A diag-
nostic laparoscopy with omental biopsy was performed. It
showed infiltration of the omentum with a poorly differ-
entiated malignant tumor consisting of sheaths of cells
with fairly uniform nuclei containing prominent nucleoli
(Figure 1).
A barium enema and flexible sigmoidoscopy showed no
bowel pathology apart from mild diverticular disease with
pedunculated polyps which were found to be benign on
histology. Immunochemical staining of the biopsy
showed features consistent with diffuse mesothelioma.
She was referred to the oncology department after a multi-
disciplinary meeting discussion and chemotherapy was
planned with cisplatin and pemetrexed. She responded
well initially and the ascites resolved with improved gen-
eral wellbeing, but the treatment was later stopped when
she developed side effects in the form of recurrent vomit-
ing and general malaise. Currently she is having palliative
treatment and is under regular oncology follow up.
Discussion
Mesothelioma is a neoplasm originating from the mes-
othelial surface lining cells of serous cavities. Most often,
mesotheliomas involve the serosal membranes of the
pleura and peritoneum. Sometimes mesothelial prolifera-
tions are identified in other locations. On rare occasions,
it has been reported in the tunica vaginalis of the testis
[1,2]. Among all cases of mesothelioma, about 80% are
pleural in origin. A causal relationship between asbestos
exposure and pleural, peritoneal and pericardial malig-
nant mesotheliomas has been suggested, the risk of cancer
being correlated with cumulative exposure. There is some
evidence that simian virus 40 may have some role in co-
carcinogenesis [1,3].
Symptomatology is insidious and poses difficult prob-
lems in diagnosis and treatment. People with peritoneal
mesothelioma generally present with one of two types of
symptoms and signs: those with abdominal pain, usually
localized and related to a dominant tumor mass with little
or no ascites, and those without abdominal pain, but with
ascites and abdominal distention [4].
Ultrasonography and CT scan of the abdomen can pro-
vide important information during the diagnostic process.
Nevertheless, a definite diagnosis can only be established
by laparoscopy or open surgery with biopsy to obtain his-
tological examination along with immunocytochemical
procedures. Laparoscopy is an important tool in the diag-
nosis of some unusual causes of ascites, such as primary
mesothelioma, which are usually overlooked by other
diagnostic modalities, such as ultrasound, CT and cytol-
ogy of the ascitic fluid. However, laparoscopy can greatly
complicate management by facilitating tumor dissemina-
tion to port sites [5].
Pathologically, a positive immunostain for calretinin has
markedly increased the accuracy of diagnosis [1]. Progno-
sis, as determined by clinical presentation, the complete-
ness of cytoreduction and gender, given that women
survive longer than men with this condition, appears to be
improved by the use of intraperitoneal chemotherapy.
Over the past decade, the management of these patients
has evolved similarly to ovarian cancer treatment and
now involves cytoreductive surgery, heated intraoperative
intraperitoneal chemotherapy (HIIC) with cisplatin and
doxorubicin, and early postoperative intraperitoneal pacl-
itaxel. These perioperative treatments are followed by
adjuvant intraperitoneal paclitaxel and second-look
cytoreduction. This multimodality treatment approach
with cytoreductive surgery and intraperitoneal chemo-
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therapy has resulted in a median survival of 50 to 60
months [1,4].
Conclusion
This case denotes the importance of considering the dif-
ferential diagnosis of common clinical problems. Perito-
neal mesothelioma, although uncommon, should be
considered in people presenting with ascites, in particular
in those where the initial diagnosis is not clear. A history
of asbestos exposure may not be present and radiological
investigations may miss the diagnosis so thorough clinical
assessment and a broad-thinking approach is important.
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